Aristo Bio-Tech & Lifescience Ltd
Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals[1]
- Market Cap ₹ 84.4 Cr.
- Current Price ₹ 124
- High / Low ₹ 164 / 72.2
- Stock P/E 20.8
- Book Value ₹ 54.8
- Dividend Yield 0.32 %
- ROCE 12.6 %
- ROE 11.4 %
- Face Value ₹ 10.0
Pros
Cons
- Company has a low return on equity of 12.8% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 57 | 159 | 271 | 202 | 201 | 167 | 166 | 218 | 245 | 318 | |
| 56 | 157 | 263 | 195 | 197 | 163 | 161 | 209 | 236 | 309 | |
| Operating Profit | 1 | 3 | 7 | 7 | 5 | 4 | 5 | 9 | 8 | 9 |
| OPM % | 2% | 2% | 3% | 3% | 2% | 3% | 3% | 4% | 3% | 3% |
| 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Interest | 0 | 1 | 2 | 2 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 3 |
| Profit before tax | 1 | 3 | 6 | 4 | 1 | 2 | 2 | 5 | 5 | 5 |
| Tax % | 33% | 31% | 34% | 31% | 28% | 29% | 27% | 25% | 28% | 26% |
| 0 | 2 | 4 | 3 | 1 | 1 | 1 | 4 | 4 | 4 | |
| EPS in Rs | 4.00 | 18.52 | 37.44 | 5.67 | 2.02 | 2.16 | 2.10 | 5.23 | 5.73 | 5.96 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 5% | 7% | 8% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 10% |
| 3 Years: | 24% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 32% |
| 3 Years: | 42% |
| TTM: | 4% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 48% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 13% |
| Last Year: | 11% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 5 | 5 | 5 | 5 | 7 | 7 | 7 |
| Reserves | 2 | 4 | 7 | 6 | 7 | 8 | 10 | 23 | 27 | 31 |
| 5 | 10 | 20 | 14 | 20 | 22 | 25 | 22 | 21 | 22 | |
| 20 | 72 | 60 | 65 | 56 | 46 | 37 | 47 | 73 | 81 | |
| Total Liabilities | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
| 2 | 2 | 8 | 8 | 8 | 12 | 14 | 16 | 22 | 24 | |
| CWIP | 0 | 0 | 0 | 1 | 3 | 0 | 0 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 25 | 85 | 81 | 81 | 77 | 69 | 63 | 83 | 106 | 117 | |
| Total Assets | 27 | 87 | 89 | 91 | 88 | 81 | 77 | 100 | 127 | 141 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| -4 | 1 | 8 | 1 | 2 | 7 | -3 | 8 | 10 | ||
| 0 | -5 | -2 | -2 | -2 | -3 | -4 | -7 | -5 | ||
| 4 | 4 | -6 | 1 | -1 | -3 | 8 | -2 | -4 | ||
| Net Cash Flow | 0 | -0 | -0 | 0 | -0 | 0 | 1 | -1 | 0 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 92 | 121 | 65 | 77 | 88 | 72 | 73 | 75 | 86 | 64 |
| Inventory Days | 66 | 67 | 42 | 65 | 47 | 78 | 60 | 57 | 65 | 59 |
| Days Payable | 142 | 177 | 85 | 124 | 74 | 93 | 87 | 85 | 112 | 97 |
| Cash Conversion Cycle | 16 | 11 | 23 | 18 | 61 | 56 | 46 | 48 | 38 | 26 |
| Working Capital Days | 30 | 26 | 27 | 28 | 37 | 51 | 56 | 56 | 47 | 38 |
| ROCE % | 31% | 34% | 24% | 14% | 11% | 11% | 16% | 13% | 13% |
Documents
Announcements
-
Structural Digital Database
29 May 2025 - Submission of SEBI compliance certificate for Structured Digital Database for FY ended March 31, 2025.
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
29 May 2025 - ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Outcome of Board Meeting-XBRL
29 May 2025 - ARISTO BIO-TECH AND LIFESCIENCE LIMITED has informed regarding Outcome of Board Meeting held on 29-May-2025 for Dividend
-
Dividend
29 May 2025 - Approved FY25 audited results with unmodified opinion; recommended 5% final dividend; company secretary changed.
-
Cessation
29 May 2025 - Approved FY25 audited results, recommended 5% final dividend, company secretary resigned and replaced.
Business Overview:[1]
ABTL, an ISO 9001:2008 certified company, manufactures, formulates, supplies, and packages various pesticides, including insecticides, herbicides, fungicides, plant growth regulators, and other agrochemicals. It currently has 257 products registered with CIB&RC for manufacturing and sales, serving both domestic and international customers.